Characterization of liver-enriched proteins binding to a developmentally demethylated site flanking the avian apoVLDLII gene.
Although the avian apoVLDLII gene is normally expressed exclusively in the liver of the laying hen, the gene can be activated by estrogen in birds of either sex beginning between days 7-9 of embryogenesis. Developmentally programmed demethylation of sites in the 5'- and 3'-flanking regions of the gene have been shown to occur during this period of embryogenesis, suggesting that they may reflect changes in protein-DNA interactions that are involved in the acquisition of competence to activate the apoVLDLII gene. We have detected specific protein interactions at one location approximately 2.6 kb upstream from the apoVLDLII gene, that includes an Msp I site whose methylation status changes between days 7 and 9 of embryogenesis. The sequence of this region bears significant similarity to binding sites of members of the bZIP family of liver-enriched or -specific factors such as C/EBP, DBP, and LAP, that are characteristically produced relatively late during liver development. In the studies described here, we demonstrate that proteins binding to the upstream apoVLDLII site do not correspond to previously identified liver-enriched or -specific factors. They also display a pattern of activity during development and in human and avian hepatoma cell lines indicating that their expression is increased in proliferating cells. Southwestern blotting and UV cross-linking studies indicate that two proteins of approximately 60 kD are capable of binding to the site and we describe the purification of these factors from crude nuclear protein extracts obtained from rooster liver.
Hoodless
P A
PA
Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada.
Ryan
A K
AK
Schrader
T J
TJ
Deeley
R G
RG
D000818:Animals; D001053:Apolipoproteins / Q000235:genetics*; D001483:Base Sequence; D001665:Binding Sites; D015139:Blotting, Southern; D015153:Blotting, Western; D002478:Cells, Cultured; D002645:Chickens; D004268:DNA-Binding Proteins / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D008079:Lipoproteins, VLDL / Q000235:genetics*; D008099:Liver / Q000737:chemistry*; D008745:Methylation; D051379:Mice; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides; D011401:Promoter Regions, Genetic; D014157:Transcription Factors / Q000378:metabolism; D014819:Vitellogenins / Q000235:genetics
D001053:Apolipoproteins; C063898:DBP protein, human; D004268:DNA-Binding Proteins; C498260:Dbp protein, mouse; C071258:LF-A1 protein, human; D008079:Lipoproteins, VLDL; D009838:Oligodeoxyribonucleotides; D014157:Transcription Factors; D014819:Vitellogenins; C027610:apolipoprotein VLDL II